Literature DB >> 34950180

Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after Resection.

I-Cheng Lee1,2, Jo-Yu Huang3, Ting-Chun Chen3, Chia-Heng Yen3,4, Nai-Chi Chiu5, Hsuen-En Hwang5, Jia-Guan Huang6, Chien-An Liu5, Gar-Yang Chau7, Rheun-Chuan Lee5, Yi-Ping Hung8, Yee Chao8, Shinn-Ying Ho3,9,10,11, Yi-Hsiang Huang1,2,12.   

Abstract

BACKGROUND AND AIMS: Current prediction models for early recurrence of hepatocellular carcinoma (HCC) after surgical resection remain unsatisfactory. The aim of this study was to develop evolutionary learning-derived prediction models with interpretability using both clinical and radiomic features to predict early recurrence of HCC after surgical resection.
METHODS: Consecutive 517 HCC patients receiving surgical resection with available contrast-enhanced computed tomography (CECT) images before resection were retrospectively enrolled. Patients were randomly assigned to a training set (n = 362) and a test set (n = 155) in a ratio of 7:3. Tumor segmentation of all CECT images including noncontrast phase, arterial phase, and portal venous phase was manually performed for radiomic feature extraction. A novel evolutionary learning-derived method called genetic algorithm for predicting recurrence after surgery of liver cancer (GARSL) was proposed to design prediction models for early recurrence of HCC within 2 years after surgery.
RESULTS: A total of 143 features, including 26 preoperative clinical features, 5 postoperative pathological features, and 112 radiomic features were used to develop GARSL preoperative and postoperative models. The area under the receiver operating characteristic curves (AUCs) for early recurrence of HCC within 2 years were 0.781 and 0.767, respectively, in the training set, and 0.739 and 0.741, respectively, in the test set. The accuracy of GARSL models derived from the evolutionary learning method was significantly better than models derived from other well-known machine learning methods or the early recurrence after surgery for liver tumor (ERASL) preoperative (AUC = 0.687, p < 0.001 vs. GARSL preoperative) and ERASL postoperative (AUC = 0.688, p < 0.001 vs. GARSL postoperative) models using clinical features only.
CONCLUSION: The GARSL models using both clinical and radiomic features significantly improved the accuracy to predict early recurrence of HCC after surgical resection, which was significantly better than other well-known machine learning-derived models and currently available clinical models.
Copyright © 2021 by The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Evolutionary learning; Hepatocellular carcinoma; Machine learning; Recurrence; Surgery

Year:  2021        PMID: 34950180      PMCID: PMC8647074          DOI: 10.1159/000518728

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  32 in total

1.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.

Authors:  Xun Xu; Hai-Long Zhang; Qiu-Ping Liu; Shu-Wen Sun; Jing Zhang; Fei-Peng Zhu; Guang Yang; Xu Yan; Yu-Dong Zhang; Xi-Sheng Liu
Journal:  J Hepatol       Date:  2019-03-13       Impact factor: 25.083

3.  Data mining in bioinformatics using Weka.

Authors:  Eibe Frank; Mark Hall; Len Trigg; Geoffrey Holmes; Ian H Witten
Journal:  Bioinformatics       Date:  2004-04-08       Impact factor: 6.937

4.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Hiroshi Imamura; Yutaka Matsuyama; Eiji Tanaka; Takao Ohkubo; Kiyoshi Hasegawa; Shinichi Miyagawa; Yasuhiko Sugawara; Masami Minagawa; Tadatoshi Takayama; Seiji Kawasaki; Masatoshi Makuuchi
Journal:  J Hepatol       Date:  2003-02       Impact factor: 25.083

5.  Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.

Authors:  Jaw-Ching Wu; Yi-Hsiang Huang; Gar-Yang Chau; Chien-Wei Su; Chung-Ru Lai; Pui-Ching Lee; Teh-Ia Huo; I-Jane Sheen; Shou-Dong Lee; Wing-Yiu Lui
Journal:  J Hepatol       Date:  2009-07-23       Impact factor: 25.083

6.  Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides.

Authors:  Charlie Saillard; Benoit Schmauch; Oumeima Laifa; Matahi Moarii; Sylvain Toldo; Mikhail Zaslavskiy; Elodie Pronier; Alexis Laurent; Giuliana Amaddeo; Hélène Regnault; Daniele Sommacale; Marianne Ziol; Jean-Michel Pawlotsky; Sébastien Mulé; Alain Luciani; Gilles Wainrib; Thomas Clozel; Pierre Courtiol; Julien Calderaro
Journal:  Hepatology       Date:  2020-12       Impact factor: 17.425

7.  Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.

Authors:  Mingyu Chen; Jiasheng Cao; Jiahao Hu; Win Topatana; Shijie Li; Sarun Juengpanich; Jian Lin; Chenhao Tong; Jiliang Shen; Bin Zhang; Jennifer Wu; Christine Pocha; Masatoshi Kudo; Amedeo Amedei; Franco Trevisani; Pil Soo Sung; Victor M Zaydfudim; Tatsuo Kanda; Xiujun Cai
Journal:  Liver Cancer       Date:  2021-01-07       Impact factor: 11.740

8.  A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme.

Authors:  Jiangwei Lao; Yinsheng Chen; Zhi-Cheng Li; Qihua Li; Ji Zhang; Jing Liu; Guangtao Zhai
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

9.  PredCRP: predicting and analysing the regulatory roles of CRP from its binding sites in Escherichia coli.

Authors:  Ming-Ju Tsai; Jyun-Rong Wang; Chi-Dung Yang; Kuo-Ching Kao; Wen-Lin Huang; Hsi-Yuan Huang; Ching-Ping Tseng; Hsien-Da Huang; Shinn-Ying Ho
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

View more
  5 in total

1.  Identification of the Immune Subtype of Hepatocellular Carcinoma for the Prediction of Disease-Free Survival Time and Prevention of Recurrence by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.

Authors:  Jie Fu; Xiaohua Lei
Journal:  Front Immunol       Date:  2022-06-06       Impact factor: 8.786

2.  Construction of a predictive nomogram and bioinformatic investigation of the potential mechanism of postoperative early recurrence of hepatocellular carcinoma meeting the Milan criteria.

Authors:  Shuqi Zhang; Liangliang Xu; Fuzhen Dai; Peng Wang; Jianchen Luo; Ming Zhang; Mingqing Xu
Journal:  Ann Transl Med       Date:  2022-08

3.  Intraoperative low-dose dopamine is associated with worse survival in patients with hepatocellular carcinoma: A propensity score matching analysis.

Authors:  Yan Wang; Ruifeng Xue; Wei Xing; Qiang Li; Liba Gei; Fang Yan; Dongmei Mai; Weian Zeng; Yan Yan; Dongtai Chen
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

4.  CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.

Authors:  Hongyang Deng; Jiaxing Zhang; Yijun Zheng; Jipin Li; Qi Xiao; Fengxian Wei; Wei Han; Xiaodong Xu; Youcheng Zhang
Journal:  Front Surg       Date:  2022-09-23

5.  Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment.

Authors:  Yuling Xiong; Peng Cao; Xiaohua Lei; Weiping Tang; Chengming Ding; Shuo Qi; Guodong Chen
Journal:  World J Surg Oncol       Date:  2022-09-30       Impact factor: 3.253

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.